These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30257323)

  • 1. Mast cell population in the development of diabetic nephropathy: Effects of renin angiotensin system inhibition.
    de Morais RB; do Couto Muniz VP; Nunes Costa E; Filho SRF; Nakamura Hiraki KR; Bispo-da-Silva LB; Coelho Balbi AP
    Biomed Pharmacother; 2018 Nov; 107():1115-1118. PubMed ID: 30257323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary cytokine profiles according to the site of blockade of the renin-angiotensin system in nephrectomized rats.
    Baracho NCDV; Silveira KDD; Rocha NP; Cordeiro TM; Feracin V; Pereira RM; Reis MAAD; Teixeira MM; Silva ACSE
    J Bras Nefrol; 2017; 39(2):108-118. PubMed ID: 29069238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the renin-angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats.
    Estato V; Obadia N; Carvalho-Tavares J; Freitas FS; Reis P; Castro-Faria Neto H; Lessa MA; Tibiriçá E
    Microvasc Res; 2013 May; 87():41-9. PubMed ID: 23466285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.
    Parreira NA; Ramalho FS; Augusto MJ; Silva DM; Prado CM; Elias Júnior J; Rodrigues V; Ramalho LNZ
    Exp Parasitol; 2018 Aug; 191():9-18. PubMed ID: 29890165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renin inhibition and the kidney].
    Ecder T
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase.
    Zhang Z; Zhang Y; Ning G; Deb DK; Kong J; Li YC
    Proc Natl Acad Sci U S A; 2008 Oct; 105(41):15896-901. PubMed ID: 18838678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes.
    Machackova J; Liu X; Lukas A; Dhalla NS
    Mol Cell Biochem; 2004 Jun; 261(1-2):271-8. PubMed ID: 15362513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
    Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH
    Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of enalapril and losartan on the events that precede diabetic nephropathy in rats.
    Volpini RA; da Silva CG; Costa RS; Coimbra TM
    Diabetes Metab Res Rev; 2003; 19(1):43-51. PubMed ID: 12592643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term therapeutic effect of vitamin D analog doxercalciferol on diabetic nephropathy: strong synergism with AT1 receptor antagonist.
    Zhang Y; Deb DK; Kong J; Ning G; Wang Y; Li G; Chen Y; Zhang Z; Strugnell S; Sabbagh Y; Arbeeny C; Li YC
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F791-801. PubMed ID: 19535571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin blockade lowers MCP-1 expression in diabetic rats.
    Kato S; Luyckx VA; Ots M; Lee KW; Ziai F; Troy JL; Brenner BM; MacKenzie HS
    Kidney Int; 1999 Sep; 56(3):1037-48. PubMed ID: 10469372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maximum renal responses to renin inhibition in healthy study participants: VTP-27999 versus aliskiren.
    Barkoudah E; van Thiel BS; Fisher ND; Gregg RA; Danser AH; Moukarbel GV; Hollenberg NK
    J Hypertens; 2016 May; 34(5):935-41. PubMed ID: 26882043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
    Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G
    Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition.
    Koszegi S; Molnar A; Lenart L; Hodrea J; Balogh DB; Lakat T; Szkibinszkij E; Hosszu A; Sparding N; Genovese F; Wagner L; Vannay A; Szabo AJ; Fekete A
    J Physiol; 2019 Jan; 597(1):193-209. PubMed ID: 30324679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ACE inhibition and angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in type 2 diabetic patients.
    Deyneli O; Yavuz D; Velioglu A; Cacina H; Aksoy N; Haklar G; Taga Y; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2006 Jun; 7(2):98-103. PubMed ID: 17083064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meprin-alpha in chronic diabetic nephropathy: interaction with the renin-angiotensin axis.
    Mathew R; Futterweit S; Valderrama E; Tarectecan AA; Bylander JE; Bond JS; Trachtman H
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F911-21. PubMed ID: 15942051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dual blockade of renin-angiotensin system in type 2 diabetes mellitus patients with diabetic nephropathy.
    Krairittichai U; Chaisuvannarat V
    J Med Assoc Thai; 2009 May; 92(5):611-7. PubMed ID: 19459520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.